Increasing Access to Definitive Treatment for Prostate Cancer

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Prostate Cancer
Interventions
OTHER

Ride Share

"The Investigators' proposed study addresses the Prostate Cancer Research Program overarching challenge of Advancing Health Equity and Reducing Disparities in PCa by examining and addressing travel burden to PCa treatment centers. Investigators will focus on Black men (including those of Caribbean descent), a high-risk population experiencing poorer health outcomes for unjust and preventable reasons.~This research will inform efforts to reduce travel burden in the healthcare acquisition process and improve the timeliness of treatment in Black men with PCa in Massachusetts and other states. This project will improve the quality of life and enhance outcomes and overall health and wellness for this group. Investigators will use findings from this pilot study to obtain future funding for a multicenter randomized clinical trial that will estimate the effect of equity - oriented programs that remove transportation barriers to treatment and reduce Black-White disparities in PCa outcomes"

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

United States Department of Defense

FED

collaborator

Dana-Farber Cancer Institute

OTHER

lead

Brigham and Women's Hospital

OTHER

NCT06034431 - Increasing Access to Definitive Treatment for Prostate Cancer | Biotech Hunter | Biotech Hunter